Non-Cash Revenue Related To The Sale Of Future Royalties was Agenus’s largest product and service line in fiscal 2025, bringing in $108.59M of $224.15M (48%).
| Product and Service | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Non-Cash Revenue Related To The Sale Of Future Royalties | $114.57M | $100.98M | $108.59M | ||||||
| Non-Cash Royalties | $114.57M | $100.98M | $108.59M | ||||||
| Research & Development | $13.60M | $482.00K | $334.00K | ||||||
| Non-Cash Royalty Revenue Related To The Sale Of Future Royalties | — | — | — | ||||||
| License Fees & Milestones | $25.00M | — | — | ||||||
| Non Cash Royalty Revenue Related To The Sale Of Future Royalties & Milestone | — | — | — | ||||||
| Royalty Sales Milestone | — | — | — | ||||||
| License & Collaboration Milestones | — | — | — | ||||||
| Recognition Of Deferred Research & Development Revenue | — | — | — | ||||||
| Research & Development Services | $1.44M | — | — | ||||||
| Pre-Commercial Product Revenue | — | — | $4.24M | ||||||
| License & Service | — | — | — | ||||||
| Recognition Of Deferred Revenue | — | — | — | ||||||
| Other Services | $2.98M | $2.00M | $1.04M | ||||||
| Service Revenue | $2.98M | $2.00M | $1.04M | ||||||
| Manufacturing Services | — | — | — | ||||||
| Other Revenue | — | — | — | ||||||
| Other Revenues | — | — | — | ||||||
| Recognition Of Deferred Grant Revenue | — | — | — | ||||||
| Grant Revenue | — | — | — | ||||||
| Clinical Product Revenue | $116.00K | $482.00K | $334.00K | ||||||
| Total | $275.25M | $206.93M | $224.15M |
Agenus brought in $224.15M from its seven product and service lines in fiscal 2025, the year ended December 31, 2025. Agenus regrouped these lines after fiscal 2024, so the total does not compare directly with that year's $206.93M. Non-Cash Revenue Related To The Sale Of Future Royalties was the largest at $108.59M (48.4%), ahead of Non-Cash Royalties at $108.59M (48.4%) and Pre-Commercial Product Revenue at $4.24M (1.9%). The other four lines brought in $2.74M combined.
Compared with fiscal 2024, Non-Cash Revenue Related To The Sale Of Future Royalties grew 7.5% to $108.59M and Non-Cash Royalties grew 7.5% to $108.59M.
Agenus began breaking out Pre-Commercial Product Revenue in fiscal 2025, when it brought in $4.24M. Agenus stopped reporting License Fees & Milestones ($25.00M in fiscal 2023) and Research & Development Services ($1.44M in fiscal 2023) as separate lines.
United States was Agenus’s largest region in fiscal 2025, bringing in $108.92M of $109.96M (99%).
| Geography | FY 2013 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $114.69M | $101.46M | $108.92M | ||||||||
| Europe | — | — | — | ||||||||
| Rest Of World | $2.98M | $2.00M | $1.04M | ||||||||
| Total | $117.67M | $103.46M | $109.96M |
Agenus brought in $109.96M from its two regions in fiscal 2025, the year ended December 31, 2025. That is less than the $224.15M it reports by product and service, so these regions do not cover all of its revenue. United States was the largest at $108.92M (99.1%), ahead of Rest Of World at $1.04M (0.9%).
Agenus (AGEN) reports its revenue by product and service and by geography. In fiscal 2025, Non-Cash Revenue Related To The Sale Of Future Royalties was its largest product and service line, bringing in $108.59M (48.4% of the total), followed by Non-Cash Royalties at $108.59M (48.4%).
Non-Cash Revenue Related To The Sale Of Future Royalties was Agenus' largest product and service line in fiscal 2025, bringing in $108.59M, or 48.4% of the $224.15M total across its seven product and service lines.
United States was Agenus' largest region in fiscal 2025, bringing in $108.92M, or 99.1% of the $109.96M total across its two regions.
Every figure comes from Agenus' annual financial filings, as reported. Each line keeps the name Agenus gives it, and years follow its fiscal calendar.
Agenus' revenue by product and service goes back to fiscal 2016, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.